|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 24, 2018 ) The global High Throughput Screening (HTS) market is anticipated to grow at 7.8% CAGR from 2017 to 2022 and it is estimated that the global market was valued at USD 13.95 billion in 2017 and is expected to reach USD 20.31 billion by 2022.
High throughput screening is a drug discovery technique used for evaluation and screening of a large number of biological modulators and effectors against a selected target. Over the last couple of years, high throughput screening has gained an extensive usage and has become a standard method of drug discovery in the pharmaceutical industry. The main idea behind this technique is to accelerate drug discovery process by screening a large number of compound libraries such as combinatorial chemistry, genomics, protein, and peptide libraries at a rate that may exceed a few thousand compounds per day or week. These methods are also used to describe metabolic, pharmacokinetic and toxicological data for new drugs and thereby eventually reducing the cost of the drug development. High throughput screening comprises of several steps such as target identification, reagent preparation, compound management, assay development and high-throughput library screening.
Browse full report @ https://www.marketdataforecast.com/market-reports/high-throughput-screening-market-6509/
Factors such as technological advancements in automation of liquid handling, the creation of novel technological platforms, and development of analytical tools to deal with massive quantities of data have exponentially driven the market for high throughput screening devices market. Growing competition among pharma companies has led to an increased demand for high throughput screening devices. HTS market is expected to witness positive growth due to its inevitable use in the research and production field. Furthermore, the increasing demand in research, huge capital investments in the HTS technology, the rise in outsourced drug discovery services, and increasing utilization rate of HTS technologies by pharmaceutical companies are key factors aiding the market growth. Be that as it may, the capital-intensive nature, need for extensive automation techniques, and high regulatory intervention and costs are turning out to be restraints for the market.
Request sample report @ https://www.marketdataforecast.com/market-reports/high-throughput-screening-market-6509/request-sample
The global High Throughput Screening market is segmented on the basis of Technology, Application, and Product. On the basis of Technology, the market is segmented into Cell-based Assays, Lab-on-a-chip, Ultra-High-Throughput Screening, and Label-Free Technology Bioinformatics. The Call- Based assays segment is further segmented into 2D and 3D Cell Culture. On the basis of Application, it is segmented into Target Identification, Primary Screening, Toxicology, Others. On the basis of product, the market is segmented into Consumables and Reagents, Instruments, and Software and Services. Consumables and reagents held the largest share of the products and services market. The presence of a wide range of reagents and continual product developments and innovations contributes to their largest share in HTS products and services market. On the basis of end users, the market is segmented into Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations and Other End Users. Other end users segment comprises of hospitals and clinics, and food, agriculture, and environmental industries. The pharmaceutical and biotechnology companies segment held the largest share of the market by end users. The widespread use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications is the major factor driving the growth of this market.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/high-throughput-screening-market-6509/inquire
On the basis of geography, the High Throughput Screening market is segmented into various regions namely North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America held the largest share of the market, followed by Europe, and Asia Pacific. Growth in the developed regions such as North America and Europe is primarily driven by the large spending on pharmaceutical R&D and high adoption of HTS and availability of government funding, and the presence of major companies in this region. Asia Pacific is expected to register the highest CAGR during the forecast period. Latin America is projected to witness lucrative growth in the coming years. This can be attributed to the growing R&D spending, rising trend of outsourcing drug discovery services; growing public-private partnerships, and increasing government funding.
Request discount @ https://www.marketdataforecast.com/market-reports/high-throughput-screening-market-6509/request-discount
The market is dominated by companies like Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad laboratories, Hamilton Company, Axxam S.p.A. and Aurora Biomed.
Buy now full report @ https://www.marketdataforecast.com/cart/buy-now/high-throughput-screening-market-6509
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
